Thalidomide treatment in cirrhotic patients with severe anemia secondary to vascular malformations

Dig Dis Sci. 2012 Apr;57(4):1112-3. doi: 10.1007/s10620-011-1971-9.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Anemia / etiology*
  • Angiogenesis Inhibitors / adverse effects
  • Angiogenesis Inhibitors / therapeutic use*
  • Female
  • Gastrointestinal Hemorrhage / drug therapy*
  • Gastrointestinal Hemorrhage / etiology
  • Hepatic Encephalopathy / chemically induced
  • Humans
  • Liver Cirrhosis / complications*
  • Male
  • Recurrence
  • Thalidomide / adverse effects
  • Thalidomide / therapeutic use*
  • Vascular Malformations / complications*

Substances

  • Angiogenesis Inhibitors
  • Thalidomide